Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3093 |
|
Actual shortage: | 247 (8%) | |
Anticipated shortage: | 14 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2823 (91%) | |
Discontinuation Reports |
356 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 334 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
32 (11%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-LANSOPRAZOLE | 30MG | CAPSULE (DELAYED RELEASE) | Resolved | 2021-04-30 | 2021-05-26 | 138346 |
APO-PROPAFENONE | 150MG | TABLET | Resolved | 2021-04-23 | 2021-05-31 | 137968 |
APO-QUETIAPINE | 100MG | TABLET | Resolved | 2021-05-14 | 2021-05-31 | 139416 |
APO-QUETIAPINE | 100MG | TABLET | Resolved | 2021-04-05 | 2021-05-31 | 136811 |
APO-QUETIAPINE | 200MG | TABLET | Resolved | 2020-08-19 | 2021-05-31 | 122495 |
APO-QUETIAPINE | 25MG | TABLET | Resolved | 2021-04-30 | 2021-05-31 | 138352 |
APO-DESVENLAFAXINE | 50MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-04-30 | 2021-06-07 | 138340 |
APO-EMTRICITABINE-TENOFOVIR | 300MG 200MG | TABLET | Resolved | 2021-04-09 | 2021-06-07 | 137241 |
APO-IBUPROFEN | 400MG | TABLET | Resolved | 2021-03-19 | 2021-06-07 | 136019 |
APO-QUETIAPINE | 300MG | TABLET | Resolved | 2021-05-14 | 2021-06-07 | 139419 |
APO-RAMIPRIL | 1.25MG | CAPSULE | Resolved | 2021-05-07 | 2021-06-07 | 138971 |
APO-AMBRISENTAN | 5MG | TABLET | Resolved | 2021-05-14 | 2021-06-14 | 139394 |
APO-AMBRISENTAN | 10MG | TABLET | Resolved | 2021-05-14 | 2021-06-14 | 139397 |
APO-ATORVASTATIN | 10MG | TABLET | Resolved | 2021-06-04 | 2021-06-14 | 140417 |
APO-CANDESARTAN | 16MG | TABLET | Resolved | 2020-06-24 | 2021-06-14 | 118761 |
APO-METFORMIN ER | 1000MG | TABLET (EXTENDED-RELEASE) | Resolved | 2021-05-14 | 2021-06-14 | 139413 |
APO-NAPROXEN EC TABLETS | 250MG | TABLET (ENTERIC-COATED) | Resolved | 2021-05-07 | 2021-06-14 | 138966 |
APO-NAPROXEN EC | 375MG | TABLET (ENTERIC-COATED) | Resolved | 2021-06-04 | 2021-06-14 | 140423 |
APO-NAPROXEN EC | 500MG | TABLET (ENTERIC-COATED) | Resolved | 2020-12-04 | 2021-06-14 | 129608 |
APO-TADALAFIL | 5MG | TABLET | Resolved | 2021-05-07 | 2021-06-14 | 138978 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-02-23 | 40757 |
APO-NITROGLYCERIN | 0.4MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40947 |
APO-TELMISARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40957 |
APO-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 40960 |
APO-FLUNISOLIDE NASAL SPRAY | 0.25MG | METERED-DOSE PUMP | Discontinued | 2018-02-26 | 2018-02-26 | 40965 |
APO-GAIN LIQ 20MG/ML | 20MG | SOLUTION | Discontinued | 2018-02-26 | 2018-02-26 | 40997 |
APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-02-28 | 40835 |
APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
APO DIMENHYDRINATE TAB 50MG | 50MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40838 |
APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40829 |
APO-TELMISARTAN/HCTZ | 25MG 80MG | TABLET | Discontinued | 2018-02-23 | 2018-05-07 | 40832 |
APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
APO-SALVENT TABLETS - 4MG | 4MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40847 |
APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
APO-IRBESARTAN/HCTZ | 12.5MG 150MG | TABLET | Discontinued | 2018-02-23 | 2018-07-17 | 40760 |
APO-ATORVASTATIN | 10MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60276 |
APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
APO-BROMAZEPAM | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |